Upload
simon-reeves
View
217
Download
0
Tags:
Embed Size (px)
Citation preview
Human SubjectsOverview
Human Subjects Office - Mission• Create an atmosphere of respect for, and awareness of, the rights
and welfare of human research participants• Continue to inform established researchers about the application of
the federal regulations and ethical principles to their particular area of research in an effort to keep researchers current with evolving standards.
• Educate students, faculty, and staff who conduct research about the ethical principles and federal regulations guiding research with humans.
• Develop new approaches that better serve the overarching mission of the HRPP, such as state-of-the-art educational materials, more efficient methods for processing applications, tracking and monitoring research activities, and assessing the overall effectiveness of the HRPP
IU’s HRPP
• Nationally accredited• Two campuses, one office• Six Institutional Review Boards (IRBs)
• 2 Social/Behavioral Boards• 4 Biomedical Boards• IRB Executive Committee
• Supported by the Office of Research Administration
Role & Authority of IRB: Protecting Human Subjects
• Approve or disapprove research and require modifications
• Conduct initial and continuing review at least annually (Except Exempt)
• Must approve any changes in research before they can be implemented
• Evaluate unanticipated problems and noncompliance
• Suspend or terminate approval of research
RESEARCH
Systematic investigati
on and designed
to develop or
contribute to
generalizable
knowledge
HUMAN SUBJECTResearch about a living
individual either
through intervention/ interaction
or identifiable
private information
IRB Revie
w
Does it require IRB review?
Questions to ask:– Is it research?– Does it involve human subjects?– Does the activity involve deceased individuals?– Is it subject to FDA regulations?– Is it a student project involving risk to human subjects?
Does it require IRB review?Levels of IRB Review
No Review Exempt(Minimal Risk)
Expedited(Minimal Risk)
Full Board
Type of Research
• Non-human subjects research
• Student projects
• Observation of public behavior
• Collection of existing data
• Surveys
• Prospective collection of data
• Non-invasive or standard of care procedures
• Focus groups
• Most drug or device studies
• Invasive procedures• Clinical trials
IRB Requirements
• Registration only if necessary
• Confirmation of exempt status
• Undocumented informed consent
• Prospective approval of any changes
• Review by an IRB member
• Written informed consent (unless waived)
• Annual review• Prospective approval
of any changes
• Review at a full IRB meeting
• Written informed consent (unless waived)
• Annual review• Prospective approval
of any changes
Minimal Risk: the risks of harm anticipated in the proposed research are not greater considering the probability and magnitude, than those ordinarily encountered in daily life or during the performance of routine physical or psychological exams or tests
Does it require IRB review?Research with Existing Data
Example Level of Review
• Review of deidentified data or specimens
• Investigators have no access to identifiable data
None – not human subjects research.
• Retrospective chart review• Access to identifiable data• Data will be recorded in a
deidentified manner
Exempt
• Retrospective chart review• Access to identifiable data• Identifiable data will be recorded
Expedited
• Prospective chart review Expedited
Does it require IRB review?Student Projects
• Class assignments • Generally not intended for publication and are not considered
research• Projects which may be more than minimal risk AND involve a
vulnerable population should be reviewed by the HSO• Application for Non-Research Student Projects
• Thesis/Dissertation projects• Are considered research and should be submitted to the HSO as a
new study• Faculty sponsor is required and have ultimate responsibility for
ensuring the project is conducted appropriately
Example #1: You want to analyze existing, coded tissue samples from 10 patients collected before and after treatment with an investigative agent. Pre- and post- tissue samples are labeled only with a code to correspond the pre-treatment sample with the same patient’s post-treatment sample; code is not associated with or linked to subject. You want to look at the efficacy of a certain treatment in patients from which the tissue was previously collected by recording differences between the tissues.
Systematic investigation Contributing to generalizable knowledge Interaction with living individuals and/or identifiable information
IRB review NOT required
Does it require IRB review?Examples
Does it require IRB review?Examples
Example #2: You want to evaluate the effectiveness of a surgical technique by analyzing data collected by a surgery registry and conducting telephone interviews with a sample of senior citizens. You would like to make a poster presentation of your findings at your next professional society meeting.
Systematic investigation Contributing to generalizable knowledge Interaction with living individuals and/or identifiable information
IRB review required – probably expedited
Does it require IRB review?Examples
Example #3: You want to evaluate whether an investigational device is more efficacious than an already approved device for treating a specific condition. You will be randomizing subjects to either of these devices and will be monitoring them with various procedures and blood draws.
Systematic investigation Contributing to generalizable knowledge Interaction with living individuals and/or identifiable information
IRB review required – full Board review
What can happen if research is not reviewed and approved by the IRB?
The data collected may not be used for research purposes, i.e. the research can not be published or presented (more journals are checking)
The IRBs can impose or have imposed sanctions on investigators that conduct research without prospective IRB approval
IRBs must notify the federal government of any serious or continuing noncompliance
Does it require IRB review?Failure to Obtain
Submitting to the IRB
• Make all submissions to [email protected] • Complete submission requirements
All investigators submit conflict of interest disclosures
All investigators complete CITI modules
Required documents submitted
• Incomplete submissions will be returned to you with a list of requirements to be completed, weekly follow-up from staff
IRB Review Process
1. Complete submission
2. Pre-review: • Each department assigned to HSO team• Completeness and understandability
3. Review (depending on level of review)
4. Provisions/concerns addressed (if necessary)
5. Approval documents sent
Ongoing Review
• Continuing review: required annually for non-exempt studies
• Amendments: all changes must be prospectively approved prior to implementation
• Including Co-Investigators (key personnel)• Research personnel updates (non-key) do
not require approval; notification only
• Reporting
Ongoing Review: ReportingUnanticipated
ProblemsNoncompliance
What to Report Any event meeting the definitions listed on the Prompt
Reporting Form
ALL noncompliance
When to Report Within 5 business days of discovery
Within 5 business days of discovery
How to Report Prompt Reporting Form Noncompliance Form
IRB Determinations
Unanticipated problem involves risk to subjects or
others (UPIRTSO)
Serious noncompliance, Continuing noncompliance, OR
Serious & continuing noncompliance
Possible IRB Actions
– No action– Restrict research activities– Conduct audit– Require remediation, mentoring, education– Require changes to protocol, informed consent process/documents, monitoring– Withdrawal, notification, or reconsenting of subjects– Suspend or terminate research
Principal Investigator Responsibilities Eligibility
• Must meet eligibility criteria• Complete submission requirements
Responsibilities• Management and completion of project• Hiring and assigning employees and resources• Ensuring appropriate training of study staff• Ensuring integrity and security of data• Ensuring consent process• Adherence to protocols and policies (federal, state, insitutional)
Additional Investigator Responsibilities
• Good Clinical Practices A standard by which clinical trials are designed, performed, monitored, audited, recorded, analyzed, and reported so that there is public assurance that the data are credible, and that the rights, integrity, and confidentiality of subjects are protected.
• Auditing• Provided by Clinical Research Compliance Office• Directed and scheduled• General audit process: notification, to site visit, to audit report,
response to findings, and then IRB Review (also see IU SOPs for Research Involving Human Subjects)
• Responsibilities related to external audits
Additional Investigator ResponsibilitiesFDA-Regulated Studies
Additional oversight: FDA• Oversight of clinical research (IND/IDEs, etc.)• Safety reporting• Accuracy of submissions• Patient enrollment• Informed consent• Records retention post approval• Financial disclosures• Inspection rights
Investigational drugs (IND) and devices (IDE)• Provide IRB with IND/IDE number • Devices: provide information regarding
significant Risk/nonsignificant for IRB determination
• If the investigator holds IND/IDE:• Meet with individuals within the Office of Research
Administration to discuss the responsibilities prior to study approval
Additional Investigator ResponsibilitiesFDA-Regulated Studies
IND Enforcement Actions• Illegal Clinical Trial
Synthes, Inc. and four top executives charged with conducting clinical device trials without FDA authorization
Label of bone cement contained a warning against the use being studied
All 4 executives were sentenced prison time – Sentencing exceeded the sentencing guidelines
Additional Investigator ResponsibilitiesFDA-Regulated Studies
CTSI-supported Indiana BiobankGoal: Create a research resource by linking a subject’s
blood sample to their medical record • Subjects consent to broad research use• Consent allows researchers to use past, present and future data in the
medical record• Over 14,000 pediatric and adult subjects already consented and
available for research studies• Studies collecting samples can partner with the Indiana Biobank to
expand this research resource• Investigators consenting subjects and collecting a blood sample for
the Indiana Biobank receive samples from the Indiana Biobank at reduced rates
To participate, contact Dr. Tatiana Foroud ([email protected])
Contact the HSO
• Submit via email to [email protected] • Contact your team:
http://researchadmin.iu.edu/HumanSubjects/hsdocs/HSO_Service_and_Support_Teams.pdf
• Visit our website:
http://researchadmin.iu.edu/HumanSubjects/ • Sign up for email updates:
http://researchadmin.iu.edu/News/email-news.html